Literature DB >> 1586814

In search of the unknown primary.

C Bradley, P Selby.   

Abstract

Mesh：

Year:  1992        PMID： 1586814      PMCID： PMC1881928          DOI： 10.1136/bmj.304.6834.1065

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

Review 1.  The limited role of radiologic imaging in patients with unknown tumor primary.

Authors:  A R Kagan; R J Steckel
Journal:  Semin Oncol       Date:  1991-04       Impact factor: 4.929

2.  Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens.

Authors:  S T Milliken; M H Tattersall; R L Woods; A S Coates; J A Levi; R M Fox; D Raghavan
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

Review 3.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

Review 4.  Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients.

Authors:  T Le Chevalier; E Cvitkovic; P Caille; J Harvey; G Contesso; M Spielmann; J Rouesse
Journal:  Arch Intern Med       Date:  1988-09

5.  Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome.

Authors:  F A Greco; W K Vaughn; J D Hainsworth
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

6.  Peritoneal carcinomatosis of unknown primary site in women. A distinctive subset of adenocarcinoma.

Authors:  C M Strnad; W W Grosh; J Baxter; L S Burnett; H W Jones; F A Greco; J D Hainsworth
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

7.  Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity.

Authors:  J D Hainsworth; D H Johnson; F A Greco
Journal:  Ann Intern Med       Date:  1988-09-01       Impact factor: 25.391

8.  Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.

Authors:  K C Gatter; C Alcock; A Heryet; D Y Mason
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

9.  Computed tomography in the evaluation of metastatic adenocarcinoma from an unknown primary site. A retrospective study.

Authors:  J H McMillan; E Levine; R H Stephens
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

10.  Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.

Authors:  S Wadler; B Lembersky; M Atkins; J Kirkwood; N Petrelli
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544
View more
  2 in total

1.  In search of the unknown primary.

Authors:  A Rodger
Journal:  BMJ       Date:  1992-05-23

2.  In search of the unknown primary.

Authors:  M P Yardley; P D Bull
Journal:  BMJ       Date:  1992-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.